A $5.8 billion deal
According to Reuters, McKesson and CD&R agreed to acquire Option Care Health in a deal worth about $5.8 billion including debt. The $32.05 per-share price represents a 37.1% premium to the last close.
Option Care shares rose 33% to $31.11 in premarket trading. After closing, the company will become privately held but remain separate, led by its existing management.
Ownership structure
The deal has notable features in its ownership structure:
- CD&R will hold a majority stake at closing.
- McKesson will invest about $1.4 billion for a 49% stake.
- McKesson has the right to buy the remaining 51% from CD&R at some point in the future.
The structure allows McKesson to expand step by step into home infusion while sharing initial investment risk with a private equity partner.

















